PSMA TARGETED RADIOHALOGENATED UREA-POLYAMINOCARBOXYLATES FOR CANCER RADIOTHERAPY

Number of patents in Portfolio can not be more than 2000

United States of America

APP PUB NO 20250057996A1
SERIAL NO

18448682

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Small molecule radiohalogenated PSMA inhibitors and metal complexes thereof and their use in radioimaging and radiotherapy for treating PSMA-related diseases, including prostate cancer, are disclosed. The combination of small molecule radiohalogenated PSMA inhibitors with a competitive PSMA ligand for reducing off-target accumulation of the radiohalogenated PSMA inhibitor also is disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE JOHNS HOPKINS UNIVERSITY34TH AND CHARLES STREET BALTIMORE MD 21218

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kumar, Vivek Baltimore, US 167 756
Mease, Ronnie C Fairfax, US 50 529
Pomper, Martin G Baltimore, US 90 527
Ray, Sangeeta Ellicott City, US 44 326
Vaidyanathan, Ganesan Chapel Hill, US 13 21
Zalutsky, Michael Chapel Hill, US 8 10

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation